Gene editing: Ethical issues 'should be discussed'

Gene editing: Ethical issues ‘should be discussed’

  • 30 September 2016
  • From the section Health

Share

  • Share this with Email

  • Share this with Facebook

  • Share this with Messenger

  • Share this with Messenger

  • Share this with Twitter

  • Share this with Pinterest

  • Share this with WhatsApp

  • Share this with Linkedin

Copy this link

http://www.bbc.co.uk/news/health-37509170

Read more about sharing.

BabyImage copyright
Thinkstock

One in six young people eat fast food 'twice a day'

One in six young people eat fast food ‘twice a day’

  • 30 September 2016
  • From the section Health

Share

  • Share this with Email

  • Share this with Facebook

  • Share this with Messenger

  • Share this with Messenger

  • Share this with Twitter

  • Share this with Pinterest

  • Share this with WhatsApp

  • Share this with Linkedin

Copy this link

http://www.bbc.co.uk/news/health-37511554

Read more about sharing.

Beef burgerImage copyright
SPL

Thailand confirms first Zika-linked microcephaly in Southeast Asia

By Aukkarapon Niyomyat
| BANGKOK

Thailand reported on Friday the first confirmed cases in Southeast Asia of microcephaly linked to mosquito-borne Zika, as the World Health Organization urged action against the virus across the region.

The confirmation of two case of microcephaly, a birth defect marked by small head size, came a day after U.S. health officials recommended that pregnant women postpone non-essential travel to 11 Southeast Asian countries because of the risk of Zika.

“We have found two cases of small heads linked to Zika, the first cases in Thailand,” Prasert Thongcharoen, an adviser to the Department of Disease Control, told reporters in Bangkok.

Regeneron's Eylea combination therapy fails mid-stage study

By Natalie Grover

Regeneron Pharmaceuticals Inc said a combination therapy containing its flagship eye drug, Eylea, was inferior to Eylea alone in a mid-stage trial involving patients with wet age-related macular degeneration (AMD), a leading cause of blindness in the elderly.

Regeneron’s shares fell 3.6 percent, and were the biggest drag on the Nasdaq biotech index. Shares of Ophthotech Corp, which is evaluating combinations of its experimental drug with Eylea or rival drugs, also fell.

Eylea sales, which have powered Regeneron’s explosive growth since late 2011, have been slowing in recent quarters, raising concerns about the biotechnology company’s growth prospects.

ASTRO: Benefit Seen for High Dose SBRT in Prostate Ca

Action Points

  • Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
  • For newly diagnosed prostate cancer, stereotactic body radiotherapy (SBRT) is safe, with a low rate of serious side effects, and cancer control rates very favorable compared to historic data, according to a multi-instouttional study.
  • Note that SBRT, which can precisely deliver high doses of radiotherapy to tumors in a small number of treatments, is a fairly new approach to prostate cancer treatment that has shown promising results in single institution studies.

The Medicare Current Beneficiary Survey: Celebrating Our 25th Anniversary and a Bright Future Ahead

September 29
by CMS

By Niall Brennan, Chief Data Officer, CMS

This year marks the 25th anniversary and the one millionth beneficiary interview for the Medicare Current Beneficiary Survey (MCBS), a survey that the Centers for Medicare & Medicaid Services (CMS) first fielded in 1991. This in-person survey of 15,000 Medicare beneficiaries collects valuable information about aspects of the Medicare program that cannot be analyzed based on CMS administrative data alone.  In particular, the MCBS gathers information on self-reported health status, satisfaction with care, and functional limitations.  The MCBS also collects information on beneficiaries that is key to understanding patient-centered care.   Beneficiary’s out-of-pocket spending and source of payment for medical services received outside the Medicare program provides a window into the “invisible” and missed costs of health care. One unique aspect of the MCBS is that it includes beneficiaries who reside in institutional settings, such as a nursing home, as well as those in the community.

Young women at 'highest mental health risk'

Young women at ‘highest mental health risk’

  • 29 September 2016
  • From the section Health

Share

  • Share this with Email

  • Share this with Facebook

  • Share this with Messenger

  • Share this with Messenger

  • Share this with Twitter

  • Share this with Pinterest

  • Share this with WhatsApp

  • Share this with Linkedin

Copy this link

http://www.bbc.co.uk/news/entertainment-arts-37504679

Read more about sharing.

Young woman looking at cameraImage copyright
SPL

Common painkillers 'increase heart failure risk'

Common painkillers ‘increase heart failure risk’

  • 29 September 2016
  • From the section Health

Share

  • Share this with Email

  • Share this with Facebook

  • Share this with Messenger

  • Share this with Messenger

  • Share this with Twitter

  • Share this with Pinterest

  • Share this with WhatsApp

  • Share this with Linkedin

Copy this link

http://www.bbc.co.uk/news/health-37496348

Read more about sharing.

NSAID painkillersImage copyright
Science Photo Library